Patient Priorities Care for Dementia (IN-TX-PPC Trial)

N/A

Recruiting

Led By Jennifer L Carnahan, MD

Research Sponsored by Indiana University

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 2 months pre and 2 months post baseline

Awards & highlights

No Placebo-Only Group

Summary

This trial will evaluate if Patient Priorities Care, a conversation that identifies and prioritizes patient goals, can improve health outcomes for those living with dementia or mild cognitive impairment.

Who is the study for?

This trial is for English-speaking patients at Indiana sites or English/Spanish speakers in Texas, aged 40+, with mild cognitive impairment or dementia. They must be treated by a participating doctor and have an outpatient visit scheduled within two months.

What is being tested?

The study tests Patient Priorities Care (PPC) in primary care and geriatrics clinics. It involves identifying eligible patients using health records, engaging them in PPC conversations about their priorities, and measuring outcomes like days at home.

What are the potential side effects?

Since this trial focuses on conversation-based intervention rather than medication, traditional side effects are not applicable. However, participants may experience emotional or psychological impacts from discussing their priorities.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 2 months pre and 2 months post baseline

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~2 months pre and 2 months post baseline

This trial's timeline: 3 weeks for screening, Varies for treatment, and 2 months pre and 2 months post baseline for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Number of patients with documentation of Patient Priorities Care discussion in the electronic health record

Secondary study objectives

Acceptability

Appropriateness

Feasibility of the intervention using Proctor et al as a guide

+6 more

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups

Experimental Treatment

Group I: Patient Priorities Care Eligible Persons Living With Dementia and Mild Cognitive ImpairmentExperimental Treatment1 Intervention

Patients (and their care partners when available) will receive a packet of information about Patient Priorities Care, and when feasible, a trained facilitator(s) will initiate a Patient Priorities Care conversation with the patient or patient care partner dyad. This conversation will be documented in the Electronic Health Record.

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Patient Priorities Care

2016

N/A

~420

Do I qualify?Apply below to find out